Found 0 matching trials
OPT-302 With Aflibercept in Neovascular Age-related Macular Degeneration (nAMD) PHASE3 A 2-year phase 3, multicentre, randomised, parallel-group, sham-controlled,...
Show More Location
COAST Investigational Site
Learn More & Join Trial
Real-world Evaluation of Prevalence of Ocular Adverse Events in Patients With Neovascular (Wet) Agerelated Macular Degeneration (AMD) Who Received Anti-VEGF Agents (IRIS Registry) N/A In this cross-sectional study of patients with wet AMD who received ≥1 anti...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
An Open-label, Dose-ascending Study of IGT001 for Retinitis Pigmentosa PHASE1 This is an investigator-initiated, prospective, single-center, open-label, ...
Show More Location
Shanghai General Hospital, Shanghai Jiao Tong University
Learn More & Join Trial
Simultaneous Therapy With Intravitreal Dexamethasone Implant and Bevacizumab for the Treatment of Macular Edema N/A Retrospective cases series is a non-randomized, open-label, single-center i...
Show More Location
Retina Clinic / UNIFESP
Learn More & Join Trial
Assessment of Early Changes in SD-OCT After Initiation of a Treatment by Intravitreal Aflibercept (EYLEA®)START PHASE4 Aflibercept (EYLEA®) induces a rapid reduction in central retinal thickness...
Show More Location
Service d'ophtalmologie Hôpital Henri Mondor 40, avenue de Verdun
Learn More & Join Trial
High-dose Topotecan for Retinoblastoma With Recurrent or Refractory Vitreous Seed EARLY_PHASE1 Retinoblastoma is the most common intraocular malignancy in infancy and chi...
Show More Location
Fudan Eye & ENT Hospital
Learn More & Join Trial
A Study To Evaluate CKD-701 and Lucentis® in Patients With Neovascular(Wet) Age Related Macular Degeneration PHASE3 This is a multicenter, randomized, double-blind, active-controlled, paralle...
Show More Location
Seoul National University Hospital
Learn More & Join Trial
Intravitreal Aflibercept for Macular Edema Due to Central Retinal Vein Occlusion PHASE4 Central retinal vein occlusion (CRVO) is a common retinal vascular disorder...
Show More Location
Multiple Locations
Learn More & Join Trial
Study Evaluating the Safety, Pharmacokinetics and Pharmacodynamics of OPT-302 With or Without Lucentis™ in Patients With Wet AMD PHASE1 The purpose of this first-in-human study is to evaluate the safety, pharmac...
Show More Location
Opthea Investigative Site
Learn More & Join Trial
A Phase 1 Safety Study of Single and Repeated Doses of JSM6427 (Intravitreal Injection) to Treat AMD PHASE1 The purpose of this study is to determine the way and rate that the study m...
Show More Location
Retina Vitreous Associates Medical Group
Learn More & Join Trial